PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 44.15
+0.05 (0.11%)
Oct 22, 2026, 5:30 PM CEST
PolyPeptide Group AG Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PolyPeptide Group AG stock has a consensus rating of "Hold" and an average price target of CHF 42.87. The average 1-year stock price forecast is 2.90% lower than the current stock price, while the lowest is CHF 39.10 (-11.44%) and the highest is CHF 43.92 (-0.52%).
Price Target: CHF 42.87 (-2.90%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for PolyPeptide Group AG stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 3 | 3 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Downgrades CHF 45.00 → CHF 44.00 | Hold | Downgrades | CHF 45.00 → CHF 44.00 | -0.34% | Oct 6, 2026 |
| Barclays | Barclays | Hold Maintains CHF 44.31 | Hold | Maintains | CHF 44.31 | +0.36% | Sep 8, 2026 |
| Berenberg Bank | Berenberg Bank | Hold Downgrades CHF 38.00 → CHF 44.00 | Hold | Downgrades | CHF 38.00 → CHF 44.00 | -0.34% | Aug 18, 2026 |
| RBC Capital | RBC Capital | Hold Downgrades CHF 44.00 | Hold | Downgrades | CHF 44.00 | -0.34% | Jul 7, 2026 |
Financial Forecast
Revenue This Year
501.92M
from 389.33M
Increased by 28.92%
Revenue Next Year
576.03M
from 501.92M
Increased by 14.77%
EPS This Year
0.79
from -0.64
EPS Next Year
1.51
from 0.79
Increased by 90.25%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.